Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
The Ensign Group, Inc. insider disclosed an option exercise and immediate sale by CEO and director Barry Port. The reporting person exercised 2,399 employee stock options with a $15.93 exercise price and sold 2,399 shares at $160 per share on 08/08/2025 under a Rule 10b5-1 trading plan adopted May 6, 2024.
The report shows the reporting persons direct beneficial ownership after the transactions as 57,030 shares and indirect beneficial ownership of 155,300 shares held of record by trusts for Barry R. Port and spouse Michelle Port. The underlying options were granted August 31, 2016 and vested over five equal annual installments.
The filing is a Form 144 for The Ensign Group, Inc. (ENSG) disclosing a proposed sale of 2,399 common shares. The seller intends to execute the transaction through Fidelity Brokerage Services LLC on or about 08/08/2025. Based on the filing, the shares carry an aggregate market value of $383,840, while the company has 57,700,157 shares outstanding. The securities were originally obtained via an employee stock option granted on 08/31/2016 and will be purchased for cash at exercise on the transaction date. No other sales by this individual occurred within the last three months. The notice affirms that the filer possesses no undisclosed material adverse information about the issuer.
The Ensign Group, Inc. (ENSG) filed Form 144 disclosing a planned sale of 425 common shares through Fidelity Brokerage Services LLC, expected on or after 31 Jul 2025. The shares have an estimated aggregate market value of $63,422.75 and represent an immaterial ~0.0007 % of the company’s 57.7 million shares outstanding.
The securities were originally received as restricted-stock vesting awards on 15 Jan 2021 (260 sh) and 15 Jul 2021 (165 sh) as compensation from the issuer. The filer reports no sales in the prior three months. Given the small size and routine nature of the transaction, the notice is unlikely to have a meaningful impact on ENSG’s share price but does signal a minor insider disposition.